Kv1.3: a potential pharmacological target for diabetes

Characterization of Ion Channels Involved in the Proliferative Response of Femoral Artery Smooth Muscle Cells

(2010) Pilar Cidad et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Kv1.3 is the exclusive voltage-gated K+channel of platelets and megakaryocytes: roles in membrane potential, Ca2+signalling and platelet count

(2010) Conor McCloskey et al.   JOURNAL OF PHYSIOLOGY-LONDON

The K+channels KCa3.1 and Kv1.3 as novel targets for asthma therapy

(2009) Peter Bradding et al.   BRITISH JOURNAL OF PHARMACOLOGY

Antiarrhythmic Drug-Induced Internalization of the Atrial-Specific K + Channel Kv1.5

(2009) Sarah M. Schumacher et al.   CIRCULATION RESEARCH

Kv1.3 channels in postganglionic sympathetic neurons: expression, function, and modulation

(2008) Megan A. Doczi et al.   AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY

Kv1.3 gene-targeted deletion alters longevity and reduces adiposity by increasing locomotion and metabolism in melanocortin-4 receptor-null mice

(2008) K Tucker et al.   INTERNATIONAL JOURNAL OF OBESITY

Kv1.3 channel as a promising therapeutic target for acquired aplastic anemia

(2008) Xiaojing Hu et al.   MEDICAL HYPOTHESES